DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Cipla Limited — Updates

NSE 1 hr ago·27 Oct 2026, 8:17 am

Cipla

Cipla Limited has informed stock exchanges about granting stock options and employee stock appreciation rights (ESARs) to its employees. These are long-term incentives that allow staff to purchase company shares at a fixed price in the future.

This move signals management's confidence in the company's growth prospects. By aligning employee interests with shareholders, it aims to retain key talent and foster a sense of ownership among the workforce.

Investors should watch for the vesting schedule and the total number of shares reserved under this plan. This information will help assess the potential dilution of existing shares and the company's commitment to its long-term strategy.